ATE24520T1 - Xylansulphate, verfahren zu deren herstellung und ihre antithrombotische und hypolipemische wirkung. - Google Patents

Xylansulphate, verfahren zu deren herstellung und ihre antithrombotische und hypolipemische wirkung.

Info

Publication number
ATE24520T1
ATE24520T1 AT84400438T AT84400438T ATE24520T1 AT E24520 T1 ATE24520 T1 AT E24520T1 AT 84400438 T AT84400438 T AT 84400438T AT 84400438 T AT84400438 T AT 84400438T AT E24520 T1 ATE24520 T1 AT E24520T1
Authority
AT
Austria
Prior art keywords
xylane
hypolipemic
antitrombotic
sulphates
effects
Prior art date
Application number
AT84400438T
Other languages
German (de)
English (en)
Inventor
Alain Bayol
Jacqueline Lansen
Jean-Pierre Maffrand
Jean-Marie Pereillo
Eric Vallee
Original Assignee
Sanofi Sa
Anic Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Anic Spa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE24520T1 publication Critical patent/ATE24520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/14—Hemicellulose; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AT84400438T 1983-03-24 1984-03-05 Xylansulphate, verfahren zu deren herstellung und ihre antithrombotische und hypolipemische wirkung. ATE24520T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8305170A FR2543145B1 (fr) 1983-03-24 1983-03-24 Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
EP84400438A EP0125152B1 (fr) 1983-03-24 1984-03-05 Nouveaux sulfates de xylanes, leur procédé de préparation et leur activité anti-thrombotique et hypolipémiante

Publications (1)

Publication Number Publication Date
ATE24520T1 true ATE24520T1 (de) 1987-01-15

Family

ID=9287351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84400438T ATE24520T1 (de) 1983-03-24 1984-03-05 Xylansulphate, verfahren zu deren herstellung und ihre antithrombotische und hypolipemische wirkung.

Country Status (16)

Country Link
US (1) US4699900A (en, 2012)
EP (1) EP0125152B1 (en, 2012)
JP (1) JPS6063203A (en, 2012)
KR (1) KR860001394B1 (en, 2012)
AT (1) ATE24520T1 (en, 2012)
AU (1) AU561588B2 (en, 2012)
CA (1) CA1221090A (en, 2012)
DE (1) DE3461808D1 (en, 2012)
DK (1) DK55784A (en, 2012)
ES (1) ES8500962A1 (en, 2012)
FR (1) FR2543145B1 (en, 2012)
GR (1) GR79831B (en, 2012)
IL (1) IL70846A0 (en, 2012)
NZ (1) NZ207622A (en, 2012)
PT (1) PT78179B (en, 2012)
ZA (1) ZA842176B (en, 2012)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
FR2574663B1 (fr) * 1984-12-17 1987-01-16 Sanofi Sa Nouvelle composition therapeutique a activite antithrombotique et hypolipemiante a base de xylanes et d'un acide organique
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
DE3917982A1 (de) * 1989-06-02 1990-12-06 Behringwerke Ag Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
ES2251289B1 (es) * 2004-02-27 2007-07-01 Bioiberica, S.A. Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
WO2009047699A1 (en) * 2007-10-10 2009-04-16 Alembic Limited An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof
AU2008100725B4 (en) * 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd A sulfated polysaccharide compound for clinical use
WO2011088418A2 (en) * 2010-01-15 2011-07-21 Mount Sinai School Of Medicine Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
WO2012101544A1 (en) * 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) * 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
BR112020003908B1 (pt) 2016-08-31 2023-01-24 Oji Holdings Corporation Método para produzir um ingrediente farmacêutico ativo incluindo polissulfato de pentosano
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
MX390883B (es) 2017-05-31 2025-03-21 Oji Holdings Corp Preparacion hidratante topica
BR112020004787A2 (pt) 2017-09-12 2020-09-24 Oji Holdings Corporation polissulfato de pentosano, composição farmacêutica, anticoagulante, e, método para produzir polissulfato de pentosano
PT3730521T (pt) * 2017-12-20 2023-06-19 Oji Holdings Corp Polissulfato de pentosano e medicamento contendo polissulfato de pentosano

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH290145A (de) * 1944-06-13 1953-04-15 Kaulla Kurt Nikolai Dr Med Von Verfahren zur Herstellung von Schwefelsäureestern des Xylans.
FR1050576A (fr) * 1951-02-06 1954-01-08 Wander Ag Dr A Procédé pour la préparation de sels alcalins de l'ester sulfurique du xylane
US3290263A (en) * 1962-08-02 1966-12-06 Colonial Sugar Refining Co Process of reacting sugars with reagents wherein the sugar is dissolved in monohydric alcohols containing grouping
ES343957A1 (es) * 1967-08-09 1968-10-01 Rocador Sa Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral.
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
US4301153A (en) * 1977-03-21 1981-11-17 Riker Laboratories, Inc. Heparin preparation
US4122250A (en) * 1977-08-22 1978-10-24 Gottfried Schmer Separation of high-activity heparin by affinity chromatography
US4221907A (en) * 1979-07-09 1980-09-09 American Cyanamid Company Substituted O-α-D and O-β-D-multi-galactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6 α-D-glucopyranoses
DE2945595A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von niedermolekularem heparin bzw. seinen salzen
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante

Also Published As

Publication number Publication date
NZ207622A (en) 1986-08-08
DE3461808D1 (en) 1987-02-05
IL70846A0 (en) 1984-05-31
ZA842176B (en) 1984-10-31
EP0125152B1 (fr) 1986-12-30
KR840008376A (ko) 1984-12-14
US4699900A (en) 1987-10-13
AU561588B2 (en) 1987-05-14
DK55784A (da) 1984-09-25
ES530266A0 (es) 1984-11-01
ES8500962A1 (es) 1984-11-01
CA1221090A (fr) 1987-04-28
KR860001394B1 (ko) 1986-09-22
DK55784D0 (da) 1984-02-08
AU2441284A (en) 1984-09-27
JPS6063203A (ja) 1985-04-11
FR2543145A1 (fr) 1984-09-28
FR2543145B1 (fr) 1986-10-17
EP0125152A1 (fr) 1984-11-14
PT78179B (fr) 1986-04-24
GR79831B (en, 2012) 1984-10-31
PT78179A (fr) 1984-04-01

Similar Documents

Publication Publication Date Title
ATE24520T1 (de) Xylansulphate, verfahren zu deren herstellung und ihre antithrombotische und hypolipemische wirkung.
IT1123805B (it) Procedimento per produrre raccordi o similari per giunti tubolari,nonche' attrezzo per attuare il procedimento e raccordo o similare prodotto secondo detto procedimento
PT76420A (de) Neue quartaere 6,11-dihydro-dibenzo-<b,e>-thiepin-11-n-lakyl-norscopinether und verfahren zu deren herstellung
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
IT7821858A0 (it) Processo per la preparazione di 2,2, 6, 6- tetrametil-4-piperidone.
PT93100A (pt) Processo para a preparacao de conservantes para composicoes aquosas
IT8419740A0 (it) Derivati dell'acido benzochinolizin carbossilico, e processo per lapreparazione di essi.
IT1226746B (it) Elemento costruttivo, nonche' metodo per la produzione dello stesso.
DE3870065D1 (de) Zusammensetzungen von polyarylalkanoligomeren, verfahren zu deren herstellung.
BR8100977A (pt) Processo para a preparacao de halogenidrato de 5,5-dimetil-2-hidrazino 1,4,5,6-tetraidropirimidina
IT1122745B (it) Procedimento per la produzione di diciclopentilen parentesi quadra aperta 2,2'-bis(4-alchil-6-t-butilfenoli)parentesi quadra chiusa
IT1193500B (it) Processo per la preparazione di 2,2'-bis/4-(1,1,3,3-tetrametilbutil) fenol/solfuro
IT1211076B (it) Processo per la preparazione di 6alfa-fluoro-delta 1,4-3-cheto steroide.
BR8504156A (pt) Processo para a preparacao de derivados de sulfonilguani-dinotriazina,composicoes herbicidas,aplicacao,processo para a preparacao de composicoes e processo para a preparacao de derivados de sulfonilisou-reidotriazina
BR8502197A (pt) Processo para a preparacao de 2,4-diamino-6-halogen-5-alquiltio-pirimidinas,composicoes herbicidas,aplicacao,composicoes fungicidas,aplicacao e processo para a preparacao de composicoes
BR7905614A (pt) Processo para a preparacao de 1,2,3-tiadiazol-5-il-ureias
BR8400755A (pt) Processo para a preparacao de alcoxi-iminoalquilamino-1,3,5-triazinas,composicoes herbicidas,emprego e processo para preparacao de composicoes
FI844392A7 (fi) Menetelmä substituoitujen 2-amino-3,4, 6,7-tetrahydro-4H-pyrimidi/6,1-a/isokinolin-4-onien valmistamiseksi.
BR7906413A (pt) Processo para a preparacao de fluor-dervados de 3,3-dimetil-butano-2-ona
BR7903439A (pt) Processo para a preparacao de (2,6-dicloro-benziliden-amino)-guanidina
BR8404744A (pt) Composicoes herbicidas,aplicacao,processo para a preparacao de composicoes
IT1216830B (it) Derivati 1,4-diidropiridinici quali agenti emoreologici
IT7827750A0 (it) Processo per la preparazione di derivati 1,4-diidro-piridinici.
BR8504146A (pt) Processo para a preparacao de derivados de oxiguanidina,composicoes herbicidas,aplicacao,processo para a preparacao de composicoes e processo para a preparacao de derivados de 4,6-dimetil-2-oxiguanidinopirimidina
BR8102579A (pt) Processo para preparacao de 2,6-dicloro-5-hidroxi-anileno

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee